Premature menopause – Meeting the needs

Post Reproductive Health

Volumn 20, Issue 2, 2014, Pages 62-68

  Shah, Duru ^a   Nagarajan, N ^a  

^a Gynaecworld   (India)

Author keywords

Cryopreservation; Menopausal hormone therapy; Oocyte donation; Oocyte embryo freezing vitrification; Premature ovarian insufficiency

Indexed keywords

CALCIUM; ESTRADIOL; ESTRADIOL VALERATE; GONADORELIN; PROGESTERONE; VITAMIN D;

AUTOIMMUNE DISEASE; CHROMOSOME ABERRATION; EARLY MENOPAUSE; FERTILITY PRESERVATION; GENE MUTATION; HORMONAL THERAPY; HUMAN; META ANALYSIS (TOPIC); OVARY POLYCYSTIC DISEASE; PREMATURE OVARIAN FAILURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING; SYSTEMATIC REVIEW (TOPIC); VIRUS INFECTION;

EID: 84922653184     PISSN: 20533691     EISSN: 20533705     Source Type: Journal    
DOI: 10.1177/2053369114531909     Document Type: Review

References (56)

1. Vujonic S. Aetiology of premature ovarian failure. Menopause Int 2009; 15: 72–75.
2. Albright F, Smith PH, Fraser R, et al. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci 1942; 204: 625–648.
3. Coulam CB, Adamson SC and Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67: 604–606.
4. Maclaran K and Panny N. Premature ovarian failure. J Fam Plann Reprod Health Care 2011; 37: 35–42.
5. Luborsky JL, Meyer P, Sower MF, et al. Premature menopause in a multi – ethnic population study of the menopause transition. Hum Reprod 2003; 18: 199–206.
6. Cramer DW, Xu H and Harlow BL. Family history as a predictor of early menopause. Fertil Steril 1995; 64: 740–745.
7. Shelling AN. Premature ovarian failure. Reproduction 2010; 140: 633–641.
8. Snowdon DA, Kane RL, Beeson WL, et al. Is early natural menopause a biologic marker of health and aging? Am J Public Health 1989; 79: 709–714.
9. Shelling AN. X chromosomes defects and premature ovarian failure. Aust NZ Med 2000; 30: 3–5.
10. Persami L, Rossetti R, Bonomi M, et al. Primary ovarian insufficiancy: X chromosomes defects and autoimmunity. J Autoimmun 2009; 33: 35–41.
11. Conway GS, Kaltsas G, Patel A, et al. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65: 337–341.
12. Di Prospero F, Luzi S and Iacopini Z. Cigarette smoking damages women’s reproductive life. Reprod Biomed Online 2004; 8: 246–242.
13. Klein P, Serje A and Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia 2001; 42: 1584–1589.
14. Green DM, Sklar CA, Boia JD Jr, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from childhood cancer survivor study. J Clin Oncol 2009; 27(14): 2374–2381.
15. Woad KJ, Watkins WJ, Prendergast D, et al. The genetic basis of premature ovarian failure. Aust NZ J Obstet Gynecol 46: 242–244.
16. Lee S, Song JY, Ku SY, et al. Fertility preservation in women with cancer. Clin Exp Reprod Med 2012; 39: 46–51.
17. Sklar CA, Mertens AC, Pauline Mitby, et al. Premature menopause in survivors of childhood cancer. A report from the childhood cancer survivor study 2006; 98(13): 890–896.
18. Bedaiway MA, Abou-Setta AM, Deasai N, et al. GnRh analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: A systemic review and metaanalysis. Fertil Steril 2011; 95: 906–914.
19. Hwang JH, Yoo HJ, Park SH, et al. Association between the location of transposed ovary and ovarian function in patients with uterine and cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril 2012; 97: 1387–1393.
20. Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long term health outcomes in the Nurses’ Health Study. Obstet Gynecol 2009; 113: 1027–1037.
21. Gelbaya TA, Nardo LG, Fitzgerald CT, et al. Ovarian response to gonadotrophins after laproscopic salphingectomy or division of fallopian tubes for hydrosalphinges. Fertil Steril 2006; 85: 1464–1468.
22. Raffi M, Metwally M and Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systemic review and metaanalysis. J Clin Endocrinol Metab 2012; 97(9): 3146–3154.
23. Weerakiet S, Lertikool S, Tingthanatikul Y, et al. Ovarian reserve in women with polycystic ovarian syndrome who underwent laproscopic ovarian drilling. Gynecol Endocrinol 2007; 23: 455–460.
24. Api M. Is ovarian reserve diminished after ovarian drilling? Gynecol Endocrinol 2009; 25: 159–165.
25. Goswami D and Conway GS. Premature ovarian failure. Hum Reprod update 2005; 11: 391–410.
26. Rebar RW, Erickson GF and Yen SS. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982; 37: 35–41.
27. Hickey M. Ambekar M and Hammond I Should the ovaries be removed or retained at the time of hysterectomy for benign disease? Hum Reprod Update 2010; 16: 131–141.
28. Paolo Beck-Pecoz and Luca Persani. Premature ovarian failure. Orphanet J Rare Dis 2006; 1: 9.
29. Alzabaidi NH, Chapin HL, Vanderhoof VH, et al. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol 2002; 99: 720–725.
30. Popat VB, Calis KA, Vanderhoof VH, et al. Bone mineral density in estrogen deficient young women. J Clin Endocrinol Metab 2009; 94: 2277–2283.
31. Christin MS. The role of HRT in management of premature ovarian failure. Nat Clin Pract Endocrinol Metab 2008; 4: 60–61.
32. de Villiers TJ, Gass MLS, Haines CJ, et al. Global consensus statement on MHT. Maturitas 2013; 74: 391–392.
33. British Menopause Society (BMS). Premature Menopause British Menopause Society Council Consensus Statement, 2007.
34. Chetkowski RJ, et al. Biologic effects of transdermal estradiol. N Engl J Med 1986; 44: 127–131.
35. Villers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on Menopausal Hormone therapy and preventive strategies for midlife health. Climacteric 2013; 6: 316–337.
36. Nelson HD. Commonly used types of postmenstrual estrogen for treatment of hot flashes: scientific review. J Am Med Assoc 2004; 291(13): 1610–1620.
37. Henzel MR and Loomba PK. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. J Reprod Med 2003; 48: 525–540.
38. Suckling J, Lethaby A and Kennedy R. Local estrogen for vaginal atrophy in postmenopausal women. Cochrane Database Systemic Reviews 2003; 4: CD001500.
39. Shifren JL. The role of androgens in female sexual dysfunction. Mayo Clin Proc 2004; 79: S19–S24.
40. Van Kasteren YM and Schoemaker J. Premature Ovarian failure: a systemic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999; 5: 483–492.
41. Rebar RW and Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53: 804–810.
42. Welt CK. Primary ovarian insufficiency, a more accurate term for premature ovarian failure. Clin Endocrinol 2009; 68: 449–509.
43. Alper MM, Jolly EE and Garner PR. Pregnancies after premature ovarian failure. Obstet Gynecol 1986; 67: 59S–62S.
44. Check JH, Chase JS and Spence M. Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotrophins therapy. Am J Obstet Gynecol 1989; 160: 114–115.
45. Tartagini M, Cicinelli E, De Pergola G, et al. Effects of pretreatment with estrogens on ovarian stimulation with gonadotrophins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril 2007; 87: 858–861.
46. Shah D. Gynaecworld and assisted fertility unit. Unpublished Data, 2007–2013.
47. Cowchock FS, McCabe JL and Montgomery BB. Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol 1988; 158: 118–119.
48. Nyobe AA, et al. Assisted reproductive technology and intrauterine insemination in Europe 2005. Hum Reprod 2009; 24: 1267–1287.
49. Oktay K, Cil AP and Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006; 86: 70.
50. Reinzi L, Romano S, Albicci L, et al. Embryo development of fresh versus vitrified metaphase II oocytes after ICSI: A prospective randomised sibling oocyte study. Hum Reprod 2010; 25: 66–73.
51. Demeestere I, Simon P, Emiliani S, et al. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist 2007; 12: 1437–1442.
52. Silber SJ, et al. Ovary cryopreservation and transplantation for fertility preservation. Mol Hum Reprod 2012; 18: 59–67.
53. Lee S and Oktay K. Does higher starting dose of FSH stimulation with Letrozole improve fertility preservation in women with breast cancer. Fertil Steril 2010; 94: S160.
54. White YA, Woods DC, Takai Y, et al. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive age women. Nat Med 2012; 18: 413–421.
55. Kawamura K, Cheng Y, Suzuki N, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA 2013; 110: 17474–17479.
56. Panay N and Fenton A. Premature ovarian insufficiency: working towards an international database. Climacteric 2012; 15: 295–296.